Lobbying

Chipps, Caffrey and Dubilier, P. S. C.'s latest lobbying report covers Q3 2025, at $9,000. Its first report covers Q3 2023; the issues it reports most are Insurance and Medical/Disease Research/Clinical Labs.

Chipps, Caffrey and Dubilier, P. S. C.

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q3 2023
The first quarter a report named it

Lobbying by quarter

Chipps, Caffrey and Dubilier, P. S. C. lobbying by quarter
Chipps, Caffrey and Dubilier, P. S. C. lobbying by quarter
QuarterAmountReports
Q3 2023$01
Q4 2023$9,0001
Q1 2024$9,0001
Q2 2024$9,0001
Q3 2024$9,0001
Q4 2024$9,0001
Q1 2025$9,0001
Q2 2025$18K2
Q3 2025$9,0001
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Insurance$40.5K · 6 reports
  • Medical research and clinical labs$31.5K · 4 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES9 reports
  • SENATE8 reports
  • Veterans Affairs, Dept of (VA)1 reports

Firms it paid

Firm
Gabbert Consulting$72K9 quarters
In-houseChipps, Caffrey and Dubilier, P. S. C.$9,0001 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
25/09/16for Q3 2025Gabbert Consulting$9,000
25/09/16for Q2 2025In-house$9,000
25/07/18for Q2 2025Gabbert Consulting$9,000
25/07/17for Q2 2025In-house$9,000
25/07/16for Q2 2025Gabbert Consulting$9,000
25/03/31for Q1 2025Gabbert Consulting$9,000
25/01/07for Q4 2024Gabbert Consulting$9,000
24/09/09for Q3 2024Gabbert Consulting$9,000
24/07/23for Q4 2023Gabbert Consulting$9,000
24/07/23for Q4 2023In-houseUnder $5,000
24/07/09for Q2 2024Gabbert Consulting$9,000
24/04/02for Q1 2024Gabbert Consulting$9,000
24/04/02for Q1 2024Gabbert ConsultingUnder $5,000
24/01/18for Q4 2023Gabbert ConsultingUnder $5,000
23/11/03for Q3 2023Gabbert ConsultingUnder $5,000
23/10/03for Q3 2023Gabbert ConsultingUnder $5,000